Clinical Trial: ECOG-ACRIN EAQ162CD

ECOG-ACRIN EAQ162CD

Status: Closed

Longitudinal Assessment of Financial Burden in Patients with Colon or Rectal Cancer Treated with Curative Intent

EAQ162CD closed to accrual Monday, July 6, 2020.